SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001387131-21-002328
Filing Date
2021-02-16
Accepted
2021-02-12 19:38:21
Documents
1
Group Members
DAVID C. OTTO. ANDREAS HALVORSENROSE S. SHABETVIKING GLOBAL EQUITIES II LPVIKING GLOBAL EQUITIES MASTER LTD.VIKING GLOBAL PERFORMANCE LLCVIKING LONG FUND GP LLCVIKING LONG FUND MASTER LTD.

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 adpt-sc13ga_123120.htm SC 13G/A 236207
  Complete submission text file 0001387131-21-002328.txt   238109
Mailing Address 55 RAILROAD AVENUE GREENWICH CT 06830
Business Address 55 RAILROAD AVENUE GREENWICH CT 06830 212-672-7050
VIKING GLOBAL INVESTORS LP (Filed by) CIK: 0001103804 (see all company filings)

IRS No.: 134055118 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 1551 EASTLAKE AVENUE EAST SUITE 200 SEATTLE WA 98102
Business Address 1551 EASTLAKE AVENUE EAST SUITE 200 SEATTLE WA 98102 206-659-0067
Adaptive Biotechnologies Corp (Subject) CIK: 0001478320 (see all company filings)

IRS No.: 270907024 | State of Incorp.: WA | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91363 | Film No.: 21631202
SIC: 2836 Biological Products, (No Diagnostic Substances)